The Swiss pharmaceutical industry should be less dependent on active ingredients from Asia, says the president of the Swiss pharmacists association, pharmaSuisse. Martine Ruggli has called for new drug companies to be built in Europe.
This content was published on
1 minute
Keystone-SDA/ts
Español
es
La industria farmacéutica suiza quiere reducir su dependencia de Asia
If a drug runs out in Switzerland, it’s not available in the whole of Europe “in an extreme situation like the present one”, she said. With Europe, Switzerland must now prepare for the future, Ruggli said in an interviewExternal link with newspaper Blick on Monday.
She pointed out that the only European company for antibiotics, for example, is in Austria. Building up new locations would take time, she said, but was possible. “Sources need to be diversified.”
Enea Martinelli, a hospital pharmacist and pharmaSuisse board member, said in November that the biggest problem was children’s medications, especially fever-reducing syrup, as well as blood pressure medications, psychiatric medications and Parkinson’s medications. Painkillers are also a problem.
More
More
Swiss pharmacists warn of medicine shortages
This content was published on
Switzerland is experiencing medicine shortages due to supply chain issues linked to Covid lockdowns in China and the Ukraine war.
Switzerland commits CHF50 million to combat rural poverty worldwide
This content was published on
The Federal Council approved a contribution of CHF49.5 million ($54.1 million) for the International Fund for Agricultural Development (IFAD).
Arrests made in raid against Turkish criminal organisation
This content was published on
A cross-border raid against a Turkish criminal organisation was conducted, including property searches in cantons Aargau and Zurich.
Up to 4,000 Swiss army soldiers to protect Ukraine peace conference
This content was published on
The Federal Council has authorised deployment of army personnel for the Ukraine peace conference on the Bürgenstock in June.
This content was published on
The business association, Swissmem, reports that there are increasing signs that the bottom of the downturn will be reached this year.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
The end of affordable medicine
This content was published on
Pharma companies are close to a cure for cancer, but will the hefty price tags make treatments unaffordable for most of the world?
Limited number of drugs account for a fifth of all costs
This content was published on
A lack of transparency around the pricing of many top-selling Swiss drugs is also a problem, said an umbrella group of health insurers on Wednesday.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.